Search Results 531-540 of 2464 for 2024embarking
Participant eligibility includes age, gender, type and stage of disease, and previous treatments or health concerns. Guidelines differ from study to study, and ...
Mayo Clinic is a collaborator on an Advanced Research Projects Agency for Health (ARPA-H) award for an innovative project accelerating the development of a ...
CHICAGO — GE HealthCare and Mayo Clinic today are announcing the GE HealthCare-Mayo Clinic Initiative in Radiation Therapy, known as GEMINI-RT, an ambitious ...
A Study to Assess the Effectiveness of Osimertinib Plus Savolitinib in Patients with Locally Advanced or Metastatic Non Small Cell Lung Cancer Who Have ...
Giving ixazomib with pomalidomide and dexamethasone may be an effective treatment for relapsed or relapsed/refractory multiple myeloma. Participation ...
Mayo Clinic Gynecologic Oncology targets a 2- to 3-week time frame for people at high risk to undergo biopsy, receive pathology results and have surgery if ...
No posts available. Explore more topics. Scroll backwards. Biotherapeutics · Clinical Trials · Discovery Science · Healthcare Delivery ...
The purpose of this study is to evaluate the clinical effectiveness, safety and tolerability of XEN1101 administered as adjunctive treatment in adult patients ...
Learn about this common cancer, including information on prevention, symptoms, diagnosis and treatment.
About this study. The objectives of this study are to compare PSA mesurements and the measured tacrolimus concentrations in patient self-collected capillary ...
Mayo Clinic does not endorse companies or products. Advertising revenue supports our not-for-profit mission.
Check out these best-sellers and special offers on books and newsletters from Mayo Clinic Press.
Your gift to celebrate this day advances our doctors’ lifesaving work.